Utilization and outcomes of mental health services among patients in drug treatment

Journal of Addictive Diseases

Volumn 25, Issue 1, 2006, Pages 73-85

  Hser, Yih Ing ^a   Grella, Christine ^a   Evans, Elizabeth ^a   Huang, Yu Chuang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

California; Drug treatment; Drug use; Mental health services

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PATIENT PARTICIPATION; SELF HELP; SUBSTANCE ABUSE; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADULT; CALIFORNIA; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 33646345817     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v25n01_10     Document Type: Article

References (45)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Study. Arch Gen Psychiatry. 1994; 51(1):8-19.
2. Kessler RC, Nelson CB, McGonagle McGonagle, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66:17-31.
3. Regier D, Narrow W, Rae D, Mandersheid R, Locke B, Goodwin F. The de facto U.S. mental and addictive disorders service system. Arch Gen Psychiatry. 1993; 50:85-94.
4. Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv. 2003; 54(3):363-69.
5. Bartels SJ, Drake RE, Wallach MA. Long-term course of substance use disorders among patients with severe mental illness. Psychiatr Serv. 1995; 46(3):248-51.
6. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry. 1996; 66(1):42-51.
7. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002; 59(4):375-80.
8. Minkoff K. Best practices: Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatr Serv. 2001a; 52:597-99.
9. McLellan AT, Luborsky L, Woody G, O'Brien, CP, Druley KA. Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry. 1983; 40(6):620-25.
10. McLellan AT, Alterman AI, Metzger DS, Grissom GR, Woody GE, Luborsky L, O'Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. J Consult Clin Psychol. 1994; 62(6):1141-58.
11. Schmitz JM, Stolls AL, Averill PM, Rothfleisch JM, Bailley SE, Sayre SL, Grabowski J. Cocaine dependence with and without comorbid depression: A comparison of patient characteristics. Drug Alcohol Depend. 2000; 60(2000):189-98.
12. Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, Rohsenow DJ. Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry. 1998; 155(2):220-5.
13. Carroll KM, Power ME, Bryant K, Rounsaville BJ. One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis. 1993; 181(2):71-9.
14. Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel ED. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003; 160(5):890-5.
15. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Arch Gen Psychiatry. 1986; 43(8):739-45.
16. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987; 44(6): 505-13.
17. Weisner C, Matzger H, Kaskutas LA. How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction. 2003; 98:901-11.
18. Brown VB, Ridgely MS, Pepper B, Levine IS, Ryglewicz H. The dual crisis: Mental illness and substance abuse. Am Psychol. 1989; 44:565-9.
19. Zweben JE. Severely and persistently mentally ill substance abusers: Clinical and policy issues. J Psychoactive Drugs. 2000; 32:383-389.
20. Osher FC, Drake RE. Reversing a history of unmet needs: Approaches to care for persons with co-occurring addictive and mental disorders. Am J Orthopsychiatry. 1996; 66(1):4-11.
21. Primm AB, Gomez MB, Tzolova-Iontchev I, Perry W, Vu HT, Crum RM. Mental health versus substance abuse treatment programs for dually diagnosed patients. J Subst Abuse Treat. 2000; 19(3):285-90.
22. Grella CE. Contrasting the views of substance misuse and mental health treatment providers on treating the dually diagnosed. Subst Use Misuse. 2003; 38(10):1433-1446.
23. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000; 26(1):105-18.
24. Watkins KE, Burnam A, Kung F, Paddock SA. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv. 2001; 52(8):1062-68.
25. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry. 2001; 158(10):1706-13.
26. Carey KB. Substance use reduction in the context of outpatient psychiatric treatment: A collaborative, motivational, harm reduction approach. Community Ment Health J. 1996; 32(3):291-306.
27. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998; 24(4):589-608.
28. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001; 52(4):469-76.
29. Roberts LJ, Shaner A, Eckman TA. Overcoming addictions: Skills training for people with schizophrenia. New York: W. W. Norton, 1999.
30. Ziedonis DM, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: Implications tor a motivation-based treatment model. Schizophr Bull. 1997; 23(2):229-38.
31. Grella CE, Gilmore J. Improving service delivery to the dually diagnosed in Los Angeles County. J Subst Abuse Treat, 2002; 23:115-22.
32. Moos RH, Finney JW, Federman EB, Suchinsky R. Specially mental health care improves patients' outcomes: Findings from a nationwide program to monitor the quality of care for patients with substance use disorders. J Stud Alcohol. 2000; 61(5):704-13.
33. Sacks S. Co-occurring mental and substance use disorders: Promising approaches and research issues. Subst Use Misuse. 2000; 35(12-14):2061-93.
34. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The DASIS report: Facilities offering special programs for dually diagnosed clients. Rockville, MD: U.S. Department of Health and Human Services, 2002.
35. Grella CE, Hser YI. A county survey of mental health services in drug treatment programs. Psychiatr Serv. 1997; 48(7):950-52.
36. Young N, Grella CE. Mental health and substance abuse treatment services for dually-diagnosed clients: Results of a state-wide survey of county administrators. J Ment Health Adm. 1998; 25(1):83-92.
37. Drake RE, Wallach MA. Dual diagnosis: 15 years of progress. Psychiatr Serv. 2000; 51(9):1126-9.
38. Grella CE, Gil-Rivas V, Cooper L. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. J Behav Health Serv Res. 2004; 31(1):38-49.
39. Jerrell JM, Wilson JL, Hiller DC. Issues and outcomes in integrated treatment programs for dual disorders. J Behav Health Serv Res. 2000; 27:303-13.
40. Hser Y-I, Evans E, Teruya C, Hardy M, Urada D, Huang Y, Picazo R, Shen H, Hsieh J, Anglin MD. Final report: The California Treatment Outcome Project. California State Department of Alcohol and Drug Programs. Los Angeles, CA: UCLA Integrated Substance Abuse Programs, 2002.
41. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980; 168:26-33.
42. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9:199-213.
43. McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP. A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis. 1992; 18:101-10.
44. De Leon G. Retention in drug-Free therapeutic communities. In: Pickens RW, Leukefeld CG, Schuster CR, eds. Improving drug abuse treatment (NIDA Research Monograph 106, DHHS Pub. No. ADM 91-1754; Rockville, MD: National Institute on Drug Abuse, 1991.
45. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD. A national evaluation of treatment outcomes for cocaine dependence Arch Gen Psychiatry. 1999; 56:507-14.